Comparison Between Coolprep and Picolyte for Bowel Cleansing
NCT ID: NCT01774175
Last Updated: 2013-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
250 participants
OBSERVATIONAL
2013-01-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Randomized Prospective Trial Comparing Polyethylene Glycol and Sodium Picosulphate With Magnesium Citrate
NCT01778192
Comparison of Bowel Cleansing Regimens Prior to Colonoscopy
NCT01649674
Sodium Picosulphate/Magnesium Citrate and Low-volume PEG -Ascorbic Acid as Preparation for Colonoscopy
NCT01603654
Comparison of Different Low Volume Solutions Prior to Colonoscopy
NCT03698474
Small Bowel Cleansing Prior to Video Capsule Endoscopy Examination
NCT00677794
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
PEG is very safe osmotic laxative. New agent(coolprep) which add ascorbic acid is less salty and less volume. Picosulfate+magnesium citrate(picolyte) taste orange, can be easily prepared bowel for colonoscopy by good taste and small volume. Magnesium with citrate acts like osmotic agent, picosulfate acts irritant agent.
The investigators will compare with PEG+ascorbic acid and picosulfate+magnesium citrate about bowel preparation, patient's satisfaction, side effects to identify effectiveness of new bowel preparation drug.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coolprep
A total of 2L A : NaCl 5.382g KCl 2.03g Sodium sulfate 15g Polyethylene glycol 3350 200.0g B : Ascorbic acid 9.4g Sodium ascorbate 11.8g
No interventions assigned to this group
Picolyte
Sodium picosulfate 30.0mg Magnesium citrate 10.5g + 36.0g
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Who will be done colonoscopy
* Who accepted informed consent
Exclusion Criteria
* Electrolyte imbalance
* Liver function test abnormality, ascites(over 2 times, \>Child class B)
* ARF or CRF(GFS\<30)
* Recent MI(\< 6months) or Unstable angina pectoris
* Congestive heart failure(NYHA \> 2)
* Inflammatory bowel disease
* Abdominal minor surgery
19 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gachon University Gil Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chung Jun Won
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jun Won Chung, Professor
Role: STUDY_DIRECTOR
Gachon University Gil Medical School
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COOLPREPICOLYTE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.